EBV ‐ LMP1 Promotes the Progression of Nasopharyngeal Carcinoma via TNC ‐Mediated Activation of PI3K /Akt Pathway
The FASEB Journal · 31.12.2025 · 39 (24)
DOI: 10.1096/fj.202502319rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, erschienen am 31.12.2025. Verfasst von Song Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Shenzhen Guangming District People's Hospital, Shenzhen, China. Hauptthemen laut MEDLINE: Viral Matrix Proteins, Nasopharyngeal Carcinoma, Proto-Oncogene Proteins c-akt, Nasopharyngeal Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Shenzhen Municipal Science and Technology Innovation Council | Shenzhen Science and Technology Innovation Program, Shenzhen Science and Technology Innovation Program.
Abstract (Originalsprache)
Nasopharyngeal carcinoma (NPC) is the most prevalent malignant tumor within the field of otolaryngology and is strongly associated with Epstein–Barr virus (EBV) infection. Among the factors linked to NPC progression, EBV‐encoded LMP1 (latent membrane protein 1) serves as a primary contributor, although the underlying mechanisms remain partially understood. In this study, we employed a lentiviral system to establish a nasopharyngeal carcinoma cell line that stably expresses EBV‐LMP1, thereby simulating the LMP1‐positive nasopharyngeal carcinoma microenvironment. Our findings reveal that LMP1 upregulates the expression of TNC, which activates the PI3K‐Akt signaling pathway, ultimately facilitating the proliferation, survival, migration, and in vivo growth of nasopharyngeal carcinoma cells. Notably, the knockdown of TNC or inhibition of PI3K‐Akt signaling significantly reverses the enhancing effects of LMP1 on the malignant progression of NPC in both in vitro and in vivo contexts. Collectively, our results provide new insights into the mechanisms through which EBV‐LMP1 contributes to the malignant progression of NPC and suggest potential strategic targets and a scientific foundation for the treatment of EBV‐related NPC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology, Shenzhen Guangming District People's Hospital, Shenzhen, China.
ORCID-Profile: Song Zhang
Förderung
- Shenzhen Municipal Science and Technology Innovation Council | Shenzhen Science and Technology Innovation Program
- Shenzhen Science and Technology Innovation Program
Zitieren
APA
Zhang, S., Tang, J., Yuan, F., Yuan, H., & Wu, S. (2025). EBV ‐ LMP1 Promotes the Progression of Nasopharyngeal Carcinoma via TNC ‐Mediated Activation of PI3K /Akt Pathway. The FASEB Journal. https://doi.org/10.1096/fj.202502319rr
Vancouver
Zhang S, Tang J, Yuan F, Yuan H, Wu S. EBV ‐ LMP1 Promotes the Progression of Nasopharyngeal Carcinoma via TNC ‐Mediated Activation of PI3K /Akt Pathway. The FASEB Journal. 2025. doi:10.1096/fj.202502319rr
BibTeX
@article{Zhang2025,
author = {Zhang, Song and Tang, Jiahui and Yuan, Foliang and Yuan, Hongyan and Wu, Shuxian},
title = {EBV ‐ LMP1 Promotes the Progression of Nasopharyngeal Carcinoma via TNC ‐Mediated Activation of PI3K /Akt Pathway},
journal = {The FASEB Journal},
year = {2025},
doi = {10.1096/fj.202502319rr}
}
EUVIMED